SHOULD WE USE THE POINT-OF-CARE FOR TESTING C-REACTIVE PROTEIN IN ORDER TO DIAGNOSE THE RESPIRATORY TRACT INFECTION IN PRIMARY HEALTH CARE?



Cite item

Full Text

Abstract

Respiratory tract infections and acute cough are the most common reason for antibiotic prescribing in primary care. Point of care test (POCT) for C-reactive protein (CRP) may significantly reduce antibiotic prescribing for low respiratory tract infections without decreasing of quality of care and result of treatment.

Full Text

НУЖНО ЛИ ИСПОЛЬЗОВАТЬ ТЕСТ НА С-РЕАКТИВНЫЙ БЕЛОК В ДИАГНОСТИКЕ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ В ОБЩЕЙ ВРАЧЕБНОЙ ПРАКТИКЕ?
×

About the authors

E A Andreeva

References

  1. Stocks N. P., McElroy H., Sayer G. P., Dyszinski K. Acute bronchitis in Australian general practise. A prescription too far? // Aust. Fam. Physician. — 2004. — № 33. — P. 91-93.
  2. Macfarlane J., Lewis S. A., Macfarlane R., Holmes W. Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practise in UK: implications for developing management guidelines // Respir. Med. — 1997. — № 91. — P. 427-434.
  3. Puhakka T., Makela M. J., Alanen A. et al. Sinusitis in the common cold // J. Allergy. Clin. Immunol. — 1998. — № 102. — P. 403-408.
  4. Melbye H., Berdal B. P., Straume B., Russel H., Worland L., Thacker W. L. Pneumonia: a clinical or radiographic diagnosis? Etiology and clinical features of lower respiratory tract infection in adult in general practise // Scand. J. Infect. Dis. — 1992. — № 24. — Р. 647-655.
  5. Hopstaken R. M. Lower respiratory tract infections in general practice: aetiology, diagnosis, management and prognosis // Maastricht University. — 2005. — 191 p.
  6. Hopstaken R. M., Muris J. W., Knottnerus J. A., Kester A. D., Rinkens P. E., Dinant G. J. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection // Br. J. Gen. Pract. — 2003. — № 53(490). — Р. 358-364.
  7. Holm A., Pedersen S. S., Nexoe J., Obel N., Nielsen L. P., Koldkjaer O., Pedersen C. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care // Br. J. Gen. Pract. — 2007. — № 57(540). — Р. 555-560.
  8. Andre M., Schwan A., Odenholt I. Swedish Study Group on Antibiotic Use. The use of CRP tests in patients with respiratory tract infections in primary care in Sweden can be questioned // Scand. J. Infect. Dis. — 2004. — № 36(3). — Р. 192-197.
  9. Woodhead M. New guidelines for the management of adult lower respiratory tract infections // Eur. Respir. J. — 2011; 38: 1250-1251.doi: 10.1183/09031936.00105211.
  10. Jakobsen K. A., Melbye H., Kelly M. J., Ceynowa C., Molstad S. et al. Influence of CRP testing and clinical findings on antibiotic prescribing in adults presenting with acute cough in primary care // Scandinavian Journal of Primary Health Care. — 2010. — № 28. — Р. 229-236.
  11. Cals J. W. L. Respiratory tract infections in general practice. Enhanced communication skills and C-reactive protein testing to optimise management // Maastricht University. — 2009.
  12. Рекомендации для диагностики и лечения острых респираторных инфекций в общей врачебной практике // Happy Audit 2008. Denmark. — 2008. — Р. 22.
  13. Melbye H., Hvidsten D., Holm A., Nordbo S. A., Brox J. The course of C-reactive protein response in untreated upper respiratory tract infection // Br. J. Gen. Pract. — 2004. — № 54(506). — Р. 653-658.
  14. Melbye H., Stocks N. Point-of-care testing of C-reactive protein. A new path for Australian GPs? // Aust. Fam. Physician. — 2006. — № 36. Р. 513-517.
  15. Engstrom S., Molstad S., Lindstrom K., Nilsson G., Borgquist L. Excessive use of rapid tests in respiratory tract infections in Swedish primary health care // Scand. J. Infect. Dis. — 2004. — № 36(3). — Р. 213-218.
  16. Bjerrum L., Gahrn-Hansen B., Munck A. P. C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis // Br. J. Gen. Pract. — 2004. — № 54(506). — Р. 659-562.
  17. Weis N., Almdal T. C-reactive protein: can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease // Eur. J. Intern. Med. — 2006. — № 17(2). — Р. 88-91.
  18. Perera W. R., Hurst J. R., Wilkinson T. M. A., Sapsford R. J., Mullerova H. et al. Inflammatory changes, recovery and recurrence at COPD exacerbation // Eur. Respir. J. — 2007. — № 29. Р. 527-534. DOI: 10. 1183/09031936. 00092506.
  19. Wouters E. F. M. The systemic face of airway diseases: the role of C-reactive protein // Eur. Respir. J. — 2006. — № 27. — Р. 877-879.
  20. Chang S. S., Vaz Fragoso C. A., Van Ness P. H., Fried L. P. and Tinetti M. E. Association between combined inter-leucin-6 and C-reactive protein levels and pulmonary function in older women: results from the Women's health and aging studies I and II // JAGS. — 2011. — № 59. — Р. 113-119.
  21. Mannino D. M., Ford E. S., Redd S. C. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination // Am. J. Med. — 2003. — № 114. — Р. 758-762.
  22. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010. // Available from: http://www.goldcopd.org. — Последний визит на сайт 31.03.2012 г.
  23. Зубаирова П. А. Особенности клинической картины, прогноз и роль биомаркеров воспаления при пневмонии у больных ХОБЛ // Автореферат диссертации на соискание ученой степени кандидата медицинских наук. Москва. 2010. http://www.pulmonology.ru/research/council.php. — Последний визит на сайт 31.03.2012 г.
  24. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике // Российское респираторное общество, Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии (МАКМАХ). Пособие для врачей. Москва. 2010 г.
  25. Cals J. W. L., Butler C. C., Hopstaken R. M., Hood K., Dinant G.-J. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial // BMJ. — 2009. — № 338:b1374 doi: 10.1136/bmj.b1374.
  26. Oppong R., Coast J., Hood K., Nuttall J., Smith R. D., Butler C. C.; GRACE-01 Study Team. Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges // Eur. J. Health Econ. — 2011. — № 12(4). — Р. 319-329. Epub 2010 Apr. 3.
  27. European Antimicrobial Resistance Surveillance System. EARSS Annual Report 2007 // Bilthoven, Netherlands: National Institute for Public Health and the Environment, 2008.
  28. Butler C. C., Hood K., Verheij T., Little P., Melbye H. et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries // BMJ. — 2009. — № 338:b2242.
  29. Smucny J., Fahey T., Becker L., Glazier R. Antibiotics for acute bronchitis // Cochrane Database Syst. Rev. — 2004. — № 18;(4):CD000245.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Andreeva E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 70763 от 21.08.2017 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies